Literature DB >> 28345210

Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.

Amanda J Abraham1, Christina M Andrews2, Marissa E Yingling3, Jerry Shannon4.   

Abstract

OBJECTIVE: To examine county-level geographic variation in treatment admissions among opioid treatment programs (OTPs) that accept Medicaid in the continental United States. DATA SOURCES/STUDY
SETTING: Data come from the 2012 National Survey of Substance Abuse Treatment Services. STUDY DESIGN/DATA COLLECTION: We used local measures of spatial autocorrelation (LISA) analysis to identify (1) clusters of counties with higher and lower than average rates of opioid use disorders and (2) clusters of counties with higher and lower than average treatment admissions among OTPs that accept Medicaid, adjusting for county population size. PRINCIPAL
FINDINGS: Our results reveal several clusters of counties with higher than average rates of opioid use disorder (OUD) and lower than average treatment admissions among OTPs that accept Medicaid. These clusters are highly concentrated in the Southeast region of the country and include Arkansas, Kentucky, Louisiana, Mississippi, and Tennessee.
CONCLUSIONS: Medicaid enrollees in areas in the Southeast have the largest gaps between county-level OUD rates and estimated county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs that accept Medicaid. Policy makers should consider strategies to increase the availability of OTPs with the capacity to serve Medicaid enrollees. © Health Research and Educational Trust.

Keywords:  Medicaid; access; opioid treatment programs; opioid use disorder

Mesh:

Year:  2017        PMID: 28345210      PMCID: PMC5785305          DOI: 10.1111/1475-6773.12686

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  25 in total

1.  State substance abuse treatment gaps.

Authors:  William E McAuliffe; Richard LaBrie; Ryan Woodworth; Caroline Zhang; Ryan P Dunn
Journal:  Am J Addict       Date:  2003 Mar-Apr

2.  Substance abuse treatment needs and access in the USA: interstate variations.

Authors:  William E McAuliffe; Ryan Dunn
Journal:  Addiction       Date:  2004-08       Impact factor: 6.526

3.  Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Authors:  Colleen M Grogan; Christina Andrews; Amanda Abraham; Keith Humphreys; Harold A Pollack; Bikki Tran Smith; Peter D Friedmann
Journal:  Health Aff (Millwood)       Date:  2016-12-01       Impact factor: 6.301

4.  Health reform and changes in health insurance coverage in 2014.

Authors:  Benjamin D Sommers; Thomas Musco; Kenneth Finegold; Munira Z Gunja; Amy Burke; Audrey M McDowell
Journal:  N Engl J Med       Date:  2014-07-23       Impact factor: 91.245

5.  Reducing public expenditures for physician services: the price of paying less.

Authors:  J R Gabel; T H Rice
Journal:  J Health Polit Policy Law       Date:  1985       Impact factor: 2.265

6.  Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform.

Authors:  Christina Andrews; Amanda Abraham; Colleen M Grogan; Harold A Pollack; Clifford Bersamira; Keith Humphreys; Peter Friedmann
Journal:  Health Aff (Millwood)       Date:  2015-05       Impact factor: 6.301

7.  Prescription practices involving opioid analgesics among Americans with Medicaid, 2010.

Authors:  Karin A Mack; Kun Zhang; Leonard Paulozzi; Christopher Jones
Journal:  J Health Care Poor Underserved       Date:  2015-02

8.  Factors that influence the willingness of private primary care pediatricians to accept more Medicaid patients.

Authors:  Steve Berman; Judith Dolins; Suk-fong Tang; Beth Yudkowsky
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

9.  Physician participation in Medicaid: evidence from California.

Authors:  J Hadley
Journal:  Health Serv Res       Date:  1979       Impact factor: 3.402

10.  Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

Authors:  Li Hui Chen; Holly Hedegaard; Margaret Warner
Journal:  NCHS Data Brief       Date:  2014-09
View more
  14 in total

1.  Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.

Authors:  Andrew S Huhn; J Gregory Hobelmann; Justin C Strickland; George A Oyler; Cecilia L Bergeria; Annie Umbricht; Kelly E Dunn
Journal:  JAMA Netw Open       Date:  2020-02-05

2.  Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020.

Authors:  Jonathan Cantor; David Powell; Aaron Kofner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

3.  Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?

Authors:  Lexie R Grove; Nikhil Rao; Marisa Elena Domino
Journal:  Addiction       Date:  2022-03-07       Impact factor: 7.256

4.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

5.  Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

Authors:  Paul J Joudrey; Nicholas Chadi; Payel Roy; Kenneth L Morford; Paxton Bach; Simeon Kimmel; Emily A Wang; Susan L Calcaterra
Journal:  Drug Alcohol Depend       Date:  2020-03-27       Impact factor: 4.492

6.  Opioid Misuse Among HIV-Positive Adults in Medical Care: Results From the Medical Monitoring Project, 2009-2014.

Authors:  Ansley Lemons; Nicholas DeGroote; Alejandro Peréz; Jason Craw; Margaret Nyaku; Dita Broz; Christine L Mattson; Linda Beer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

7.  Incorporating space and time into random forest models for analyzing geospatial patterns of drug-related crime incidents in a major U.S. metropolitan area.

Authors:  Zhiyue Xia; Kathleen Stewart; Junchuan Fan
Journal:  Comput Environ Urban Syst       Date:  2021-01-29

8.  Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.

Authors:  Suzan Iloglu; Paul J Joudrey; Emily A Wang; Thomas A Thornhill; Gregg Gonsalves
Journal:  Drug Alcohol Depend       Date:  2021-01-19       Impact factor: 4.492

9.  Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017.

Authors:  Shaheen Kurani; Rozalina Grubina McCoy; Jonathan Inselman; Molly Moore Jeffery; Sagar Chawla; Lila J Finney Rutten; Rachel Giblon; Nilay D Shah
Journal:  BMJ Open       Date:  2020-05-17       Impact factor: 2.692

Review 10.  Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.

Authors:  Amanda J Abraham; Christina M Andrews; Samantha J Harris; Peter D Friedmann
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.